Medical assessment of adverse health outcomes in Dutch childhood cancer survivors; a nationwide project; SKION LATER Q2008 - Metabolic syndrome parameters in adult survivors of childhood cancer

Medical assessment of adverse health outcomes in Dutch childhood cancer survivors; a nationwide project; SKION LATER Q2008 - Metabolic syndrome parameters in adult survivors of childhood cancer - SKION LATER Q2008 - metabolic syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47840

Enrollment

5000

Registered

2014-01-23

Start date

2016-05-04

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adiposity high bloodpressure

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients who were treated for childhood cancer (before age 18) in one of the Pediatric Oncology Centers between 1960 and 2004 and who survived for at least 5 years after diagnosis will be included in the SKION LATER- metabolic syndrome study. Participating centres are located in Amsterdam (VU University Medical Center (VUMC)), Groningen (Children's Cancer Center/ University Medical Center Groningen (UMCG)), Rotterdam (Rotterdam Erasmus MC-Sophia (REMC-S), Nijmegen (University Medical Center Nijmegen (UMCN)), Leiden (Leiden University Medical Center (LUMC) and Utrecht (Princess Máxima Center for Pediatric Oncology (PMC)).

Exclusion criteria

Exclusion criteria: diagnosis of childhood cancer with survival less than 5 years, age at diagnosis >17 years or diagnosis while residing in foreign country

Design outcomes

Secondary

Measure	Time frame
nvt	—

Primary

Measure	Time frame
Prevalence of metabolic syndrome or its denominators (body composition, hypertension, DM, Fat spectrum)	—

Countries

Netherlands

Outcome results